The VOLFI trial enrolled 105 patients with RAS wild-type metastatic colorectal cancer.
Christina Bennett, MS
A combination of trifluridine and tipiracil showed some gains in overall survival for patients with metastatic gastric cancer or gastroesophageal junction cancer.
Combination therapy with nivolumab and bevacizumab appeared to have clinical activity in ovarian cancer patients with platinum-sensitive or platinum-resistant disease.
BRAF and MEK inhibitors appear to have clinical activity in patients with metastatic melanoma with rare BRAF mutations.
A new study looked at the characteristics of diagnosed breast cancer cases in San Francisco.
A study showed patients seem to lack an understanding of the meaning of progression-free survival.
The study found patients with lung cancer referred to palliative care earlier lived longer.
The results of the TAILORx trial went against previous ideas that breast cancer patients with a high Oncotype score who needed chemotherapy and endocrine therapy wouldn't fare well.
Maintenance therapy with niraparib may improve survival in patients with ovarian cancer.
Adding PARP inhibitors to maintenance therapy was shown to prolong progression-free survival in patients with advanced ovarian cancer.